Calcium Signalling in Breast Cancer Associated Bone Pain
Abstract
:1. Introduction
2. An Overview on Calcium Signalling Mechanisms
3. Calcium Signalling in Breast Cancer
3.1. Ca2+ Channels
3.2. Calcium Pumps
3.3. Mitochondria in Ca2+ Signalling
3.4. Calcium-Sensing Receptor
4. Calcium Signalling in Pain
4.1. NMDARs and AMPARs
4.2. P2XRs
4.3. VOCCs
4.4. Endoplasmic Reticulum Calcium Release
4.5. PMCA
4.6. NCXs
4.7. Mitochondrial Contribution in Pain Signalling
5. Cancer Bone Pain
Calcium Signalling in Cancer Bone Pain
6. Conclusions
Author Contributions
Funding
Conflicts of Interest
References
- So, C.L.; Saunus, J.M.; Roberts-Thomson, S.J.; Monteith, G.R. Calcium signalling and breast cancer. Semin. Cell Dev. Biol. 2019, 94, 74–83. [Google Scholar] [CrossRef] [PubMed]
- Shemanko, C.S.; Cong, Y.; Forsyth, A. What Is Breast in the Bone? Int. J. Mol. Sci. 2016, 17, 1764. [Google Scholar] [CrossRef] [PubMed]
- Bloom, A.P.; Jimenez-Andrade, J.M.; Taylor, R.N.; Castañeda-Corral, G.; Kaczmarska, M.J.; Freeman, K.T.; Coughlin, K.A.; Ghilardi, J.R.; Kuskowski, M.A.; Mantyh, P.W. Breast Cancer-Induced Bone Remodeling, Skeletal Pain, and Sprouting of Sensory Nerve Fibers. J. Pain 2011, 12, 698–711. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wang, W.; Li, L.; Chen, N.; Niu, C.; Li, Z.; Hu, J.; Cui, J. Nerves in the Tumor Microenvironment: Origin and Effects. Front. Cell Dev. Biol. 2020, 8, 601738. [Google Scholar] [CrossRef] [PubMed]
- Berridge, M.J.; Bootman, M.D.; Roderick, H.L. Calcium signalling: Dynamics, homeostasis and remodelling. Nat. Rev. Mol. Cell Biol. 2003, 4, 517–529. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Berridge, M.J.; Lipp, P.; Bootman, M.D. The versatility and universality of calcium signalling. Nat. Rev. Mol. Cell Biol. 2000, 1, 11–21. [Google Scholar] [CrossRef]
- Carafoli, E.; Santella, L.; Branca, D.; Brini, M. Generation, control, and processing of cellular calcium signals. Crit. Rev. Biochem. Mol. Biol. 2001, 36, 107–260. [Google Scholar] [CrossRef]
- Bootman, M.D.; Berridge, M.J.; Roderick, H.L. Calcium signalling: More messengers, more channels, more complexity. Curr. Biol. 2002, 12, R563–R565. [Google Scholar] [CrossRef] [Green Version]
- Pchitskaya, E.; Popugaeva, E.; Bezprozvanny, I. Calcium signaling and molecular mechanisms underlying neurodegenerative diseases. Cell Calcium 2018, 70, 87–94. [Google Scholar] [CrossRef]
- Mignen, O.; Shuttleworth, T.J. I(ARC), a novel arachidonate-regulated, noncapacitative Ca(2+) entry channel. J. Biol. Chem. 2000, 275, 9114–9119. [Google Scholar] [CrossRef] [Green Version]
- Bird, G.S.; Putney, J.W. Pharmacology of Store-Operated Calcium Entry Channels. In Calcium Entry Channels in Non-Excitable Cells; Kozak, J.A., Putney, J.W., Eds.; CRC Press/Taylor & Francis: Boca Raton, FL, USA, 2018. [Google Scholar]
- Wu, L.J.; Sweet, T.B.; Clapham, D.E. International Union of Basic and Clinical Pharmacology. LXXVI. Current Progress in the Mammalian TRP Ion Channel Family. Pharmacol. Rev. 2010, 62, 381–404. [Google Scholar] [CrossRef] [PubMed]
- González-Ramírez, R.; Chen, Y.; Liedtke, W.B.; Morales-Lázaro, S.L. TRP Channels and Pain. In Neurobiology of TRP Channels; Emir, T.L.R., Ed.; Frontiers in Neuroscience; CRC Press/Taylor & Francis: Boca Raton, FL, USA, 2017. [Google Scholar]
- Hagenston, A.M.; Simonetti, M. Neuronal calcium signaling in chronic pain. Cell Tissue Res. 2014, 357, 407–426. [Google Scholar] [CrossRef] [PubMed]
- Frandsen, S.K.; Gissel, H.; Hojman, P.; Tramm, T.; Eriksen, J.; Gehl, J. Direct Therapeutic Applications of Calcium Electroporation to Effectively Induce Tumor Necrosis. Cancer Res. 2012, 72, 1336–1341. [Google Scholar] [CrossRef] [Green Version]
- Falk, H.; Matthiessen, L.W.; Wooler, G.; Gehl, J. Calcium electroporation for treatment of cutaneous metastases; a randomized double-blinded phase II study, comparing the effect of calcium electroporation with electrochemotherapy. Acta Oncol. 2018, 57, 311–319. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- den Dekker, E.; Hoenderop, J.G.J.; Nilius, B.; Bindels, R.J.M. The epithelial calcium channels, TRPV5 & TRPV6: From identification towards regulation. Cell Calcium 2003, 33, 497–507. [Google Scholar] [CrossRef]
- Peters, A.A.; Simpson, P.T.; Bassett, J.J.; Lee, J.M.; Silva, L.D.; Reid, L.E.; Song, S.; Parat, M.O.; Lakhani, S.R.; Kenny, P.A.; et al. Calcium Channel TRPV6 as a Potential Therapeutic Target in Estrogen Receptor–Negative Breast Cancer. Mol. Cancer Ther. 2012, 11, 2158–2168. [Google Scholar] [CrossRef] [Green Version]
- Bolanz, K.A.; Hediger, M.A.; Landowski, C.P. The role of TRPV6 in breast carcinogenesis. Mol. Cancer Ther. 2008, 7, 271–279. [Google Scholar] [CrossRef] [Green Version]
- Dhennin-Duthille, I.; Gautier, M.; Faouzi, M.; Guilbert, A.; Brevet, M.; Vaudry, D.; Ahidouch, A.; Sevestre, H.; Ouadid-Ahidouch, H. High Expression of Transient Receptor Potential Channels in Human Breast Cancer Epithelial Cells and Tissues: Correlation with Pathological Parameters. CPB 2011, 28, 813–822. [Google Scholar] [CrossRef]
- Fu, S.; Hirte, H.; Welch, S.; Ilenchuk, T.T.; Lutes, T.; Rice, C.; Fields, N.; Nemet, A.; Dugourd, D.; Piha-Paul, S.; et al. First-in-human phase I study of SOR-C13, a TRPV6 calcium channel inhibitor, in patients with advanced solid tumors. Investig. New Drugs 2017, 35, 324–333. [Google Scholar] [CrossRef] [Green Version]
- Singh, A.K.; Saotome, K.; McGoldrick, L.L.; Sobolevsky, A.I. Structural bases of TRP channel TRPV6 allosteric modulation by 2-APB. Nat. Commun. 2018, 9, 2465. [Google Scholar] [CrossRef]
- Bhardwaj, R.; Lindinger, S.; Neuberger, A.; Nadezhdin, K.D.; Singh, A.K.; Cunha, M.R.; Derler, I.; Gyimesi, G.; Reymond, J.L.; Hediger, M.A.; et al. Inactivation-mimicking block of the epithelial calcium channel TRPV6. Sci. Adv. 2020, 6, eabe1508. [Google Scholar] [CrossRef] [PubMed]
- Cunha, M.R.; Bhardwaj, R.; Carrel, A.L.; Lindinger, S.; Romanin, C.; Parise-Filho, R.; Hediger, M.A.; Reymond, J.L. Natural product inspired optimization of a selective TRPV6 calcium channel inhibitor. RSC Med. Chem. 2020, 11, 1032–1040. [Google Scholar] [CrossRef] [PubMed]
- Neuberger, A.; Nadezhdin, K.D.; Sobolevsky, A.I. Structural mechanisms of TRPV6 inhibition by ruthenium red and econazole. Nat. Commun. 2021, 12, 6284. [Google Scholar] [CrossRef] [PubMed]
- Lee, W.H.; Choong, L.Y.; Mon, N.N.; Lu, S.; Lin, Q.; Pang, B.; Yan, B.; Krishna, V.S.R.; Singh, H.; Tan, T.Z.; et al. TRPV4 Regulates Breast Cancer Cell Extravasation, Stiffness and Actin Cortex. Sci. Rep. 2016, 6, 27903. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lee, W.H.; Choong, L.Y.; Jin, T.H.; Mon, N.N.; Chong, S.; Liew, C.S.; Putti, T.; Lu, S.Y.; Harteneck, C.; Lim, Y.P. TRPV4 plays a role in breast cancer cell migration via Ca2+-dependent activation of AKT and downregulation of E-cadherin cell cortex protein. Oncogenesis 2017, 6, e338. [Google Scholar] [CrossRef] [PubMed]
- Peters, A.A.; Jamaludin, S.Y.N.; Yapa, K.T.D.S.; Chalmers, S.; Wiegmans, A.P.; Lim, H.F.; Milevskiy, M.J.G.; Azimi, I.; Davis, F.M.; Northwood, K.S.; et al. Oncosis and apoptosis induction by activation of an overexpressed ion channel in breast cancer cells. Oncogene 2017, 36, 6490–6500. [Google Scholar] [CrossRef] [Green Version]
- Middelbeek, J.; Kuipers, A.J.; Henneman, L.; Visser, D.; Eidhof, I.; Horssen, R.v.; Wieringa, B.; Canisius, S.V.; Zwart, W.; Wessels, L.F.; et al. TRPM7 Is Required for Breast Tumor Cell Metastasis. Cancer Res. 2012, 72, 4250–4261. [Google Scholar] [CrossRef] [Green Version]
- Guilbert, A.; Gautier, M.; Dhennin-Duthille, I.; Haren, N.; Sevestre, H.; Ouadid-Ahidouch, H. Evidence that TRPM7 is required for breast cancer cell proliferation. Am. J. Physiol.-Cell Physiol. 2009, 297, C493–C502. [Google Scholar] [CrossRef]
- Takahashi, N.; Chen, H.Y.; Harris, I.S.; Stover, D.G.; Selfors, L.M.; Bronson, R.T.; Deraedt, T.; Cichowski, K.; Welm, A.L.; Mori, Y.; et al. Cancer Cells Co-opt the Neuronal Redox-Sensing Channel TRPA1 to Promote Oxidative-Stress Tolerance. Cancer Cell 2018, 33, 985–1003.e7. [Google Scholar] [CrossRef] [Green Version]
- Ma, X.; Cai, Y.; He, D.; Zou, C.; Zhang, P.; Lo, C.Y.; Xu, Z.; Chan, F.L.; Yu, S.; Chen, Y.; et al. Transient receptor potential channel TRPC5 is essential for P-glycoprotein induction in drug-resistant cancer cells. Proc. Natl. Acad. Sci. USA 2012, 109, 16282–16287. [Google Scholar] [CrossRef] [Green Version]
- Ma, X.; Chen, Z.; Hua, D.; He, D.; Wang, L.; Zhang, P.; Wang, J.; Cai, Y.; Gao, C.; Zhang, X.; et al. Essential role for TrpC5-containing extracellular vesicles in breast cancer with chemotherapeutic resistance. Proc. Natl. Acad. Sci. USA 2014, 111, 6389–6394. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Davis, F.M.; Janoshazi, A.; Janardhan, K.S.; Steinckwich, N.; D’Agostin, D.M.; Petranka, J.G.; Desai, P.N.; Roberts-Thomson, S.J.; Bird, G.S.; Tucker, D.K.; et al. Essential role of Orai1 store-operated calcium channels in lactation. Proc. Natl. Acad. Sci. USA 2015, 112, 5827–5832. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- McAndrew, D.; Grice, D.M.; Peters, A.A.; Davis, F.M.; Stewart, T.; Rice, M.; Smart, C.E.; Brown, M.A.; Kenny, P.A.; Roberts-Thomson, S.J.; et al. ORAI1-Mediated Calcium Influx in Lactation and in Breast Cancer. Mol. Cancer Ther. 2011, 10, 448–460. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Feng, M.; Grice, D.M.; Faddy, H.M.; Nguyen, N.; Leitch, S.; Wang, Y.; Muend, S.; Kenny, P.A.; Sukumar, S.; Roberts-Thomson, S.J.; et al. Store-Independent Activation of Orai1 by SPCA2 in Mammary Tumors. Cell 2010, 143, 84–98. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Badaoui, M.; Mimsy-Julienne, C.; Saby, C.; Gulick, L.V.; Peretti, M.; Jeannesson, P.; Morjani, H.; Ouadid-Ahidouch, H. Collagen type 1 promotes survival of human breast cancer cells by overexpressing Kv10.1 potassium and Orai1 calcium channels through DDR1-dependent pathway. Oncotarget 2018, 9, 24653–24671. [Google Scholar] [CrossRef] [PubMed]
- Motiani, R.K.; Abdullaev, I.F.; Trebak, M. A novel native store-operated calcium channel encoded by Orai3: Selective requirement of Orai3 versus Orai1 in estrogen receptor-positive versus estrogen receptor-negative breast cancer cells. J. Biol. Chem. 2010, 285, 19173–19183. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Faouzi, M.; Hague, F.; Potier, M.; Ahidouch, A.; Sevestre, H.; Ouadid-Ahidouch, H. Down-regulation of Orai3 arrests cell-cycle progression and induces apoptosis in breast cancer cells but not in normal breast epithelial cells. J. Cell. Physiol. 2011, 226, 542–551. [Google Scholar] [CrossRef]
- Faouzi, M.; Kischel, P.; Hague, F.; Ahidouch, A.; Benzerdjeb, N.; Sevestre, H.; Penner, R.; Ouadid-Ahidouch, H. ORAI3 silencing alters cell proliferation and cell cycle progression via c-myc pathway in breast cancer cells. Biochim. Biophys. Acta (BBA)-Mol. Cell Res. 2013, 1833, 752–760. [Google Scholar] [CrossRef] [Green Version]
- Motiani, R.K.; Zhang, X.; Harmon, K.E.; Keller, R.S.; Matrougui, K.; Bennett, J.A.; Trebak, M. Orai3 is an estrogen receptor a-regulated Ca2+ channel that promotes tumorigenesis. FASEB J. 2013, 27, 63–75. [Google Scholar] [CrossRef] [Green Version]
- Kar, P.; Lin, Y.P.; Bhardwaj, R.; Tucker, C.J.; Bird, G.S.; Hediger, M.A.; Monico, C.; Amin, N.; Parekh, A.B. The N terminus of Orai1 couples to the AKAP79 signaling complex to drive NFAT1 activation by local Ca2+ entry. Proc. Natl. Acad. Sci. USA 2021, 118, e2012908118. [Google Scholar] [CrossRef]
- Hasna, J.; Hague, F.; Rodat-Despoix, L.; Geerts, D.; Leroy, C.; Tulasne, D.; Ouadid-Ahidouch, H.; Kischel, P. Orai3 calcium channel and resistance to chemotherapy in breast cancer cells: The p53 connection. Cell Death Differ. 2018, 25, 693–707. [Google Scholar] [CrossRef] [PubMed]
- Schild, A.; Bhardwaj, R.; Wenger, N.; Tscherrig, D.; Kandasamy, P.; Dernič, J.; Baur, R.; Peinelt, C.; Hediger, M.A.; Lochner, M. Synthesis and Pharmacological Characterization of 2-Aminoethyl Diphenylborinate (2-APB) Derivatives for Inhibition of Store-Operated Calcium Entry (SOCE) in MDA-MB-231 Breast Cancer Cells. Int. J. Mol. Sci. 2020, 21, 5604. [Google Scholar] [CrossRef] [PubMed]
- Mound, A.; Rodat-Despoix, L.; Bougarn, S.; Ouadid-Ahidouch, H.; Matifat, F. Molecular interaction and functional coupling between type 3 inositol 1,4,5-trisphosphate receptor and BKCa channel stimulate breast cancer cell proliferation. Eur. J. Cancer 2013, 49, 3738–3751. [Google Scholar] [CrossRef] [PubMed]
- Curry, M.C.; Luk, N.A.; Kenny, P.A.; Roberts-Thomson, S.J.; Monteith, G.R. Distinct regulation of cytoplasmic calcium signals and cell death pathways by different plasma membrane calcium ATPase isoforms in MDA-MB-231 breast cancer cells. J. Biol. Chem. 2012, 287, 28598–28608. [Google Scholar] [CrossRef] [Green Version]
- Cárdenas, C.; Müller, M.; McNeal, A.; Lovy, A.; Jaňa, F.; Bustos, G.; Urra, F.; Smith, N.; Molgó, J.; Diehl, J.A.; et al. Selective Vulnerability of Cancer Cells by Inhibition of Ca2+ Transfer from Endoplasmic Reticulum to Mitochondria. Cell Rep. 2016, 14, 2313–2324. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Jeong, J.; VanHouten, J.N.; Dann, P.; Kim, W.; Sullivan, C.; Yu, H.; Liotta, L.; Espina, V.; Stern, D.F.; Friedman, P.A.; et al. PMCA2 regulates HER2 protein kinase localization and signaling and promotes HER2-mediated breast cancer. Proc. Natl. Acad. Sci. USA 2016, 113, E282–E290. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Peters, A.A.; Milevskiy, M.J.G.; Lee, W.C.; Curry, M.C.; Smart, C.E.; Saunus, J.M.; Reid, L.; da Silva, L.; Marcial, D.L.; Dray, E.; et al. The calcium pump plasma membrane Ca2+-ATPase 2 (PMCA2) regulates breast cancer cell proliferation and sensitivity to doxorubicin. Sci. Rep. 2016, 6, 25505. [Google Scholar] [CrossRef]
- Bassett, J.J.; Bong, A.H.L.; Janke, E.K.; Robitaille, M.; Roberts-Thomson, S.J.; Peters, A.A.; Monteith, G.R. Assessment of cytosolic free calcium changes during ceramide-induced cell death in MDA-MB-231 breast cancer cells expressing the calcium sensor GCaMP6m. Cell Calcium 2018, 72, 39–50. [Google Scholar] [CrossRef]
- VanHouten, J.; Sullivan, C.; Bazinet, C.; Ryoo, T.; Camp, R.; Rimm, D.L.; Chung, G.; Wysolmerski, J. PMCA2 regulates apoptosis during mammary gland involution and predicts outcome in breast cancer. Proc. Natl. Acad. Sci. USA 2010, 107, 11405–11410. [Google Scholar] [CrossRef] [Green Version]
- Baggott, R.R.; Mohamed, T.M.A.; Oceandy, D.; Holton, M.; Blanc, M.C.; Roux-Soro, S.C.; Brown, S.; Brown, J.E.; Cartwright, E.J.; Wang, W.; et al. Disruption of the interaction between PMCA2 and calcineurin triggers apoptosis and enhances paclitaxel-induced cytotoxicity in breast cancer cells. Carcinogenesis 2012, 33, 2362–2368. [Google Scholar] [CrossRef] [Green Version]
- Faddy, H.M.; Smart, C.E.; Xu, R.; Lee, G.Y.; Kenny, P.A.; Feng, M.; Rao, R.; Brown, M.A.; Bissell, M.J.; Roberts-Thomson, S.J.; et al. Localization of plasma membrane and secretory calcium pumps in the mammary gland. Biochem. Biophys. Res. Commun. 2008, 369, 977–981. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Grice, D.M.; Vetter, I.; Faddy, H.M.; Kenny, P.A.; Roberts-Thomson, S.J.; Monteith, G.R. Golgi calcium pump secretory pathway calcium ATPase 1 (SPCA1) is a key regulator of insulin-like growth factor receptor (IGF1R) processing in the basal-like breast cancer cell line MDA-MB-231. J. Biol. Chem. 2010, 285, 37458–37466. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sehgal, P.; Szalai, P.; Olesen, C.; Praetorius, H.A.; Nissen, P.; Christensen, S.B.; Engedal, N.; Møller, J.V. Inhibition of the sarco/endoplasmic reticulum (ER) Ca2+-ATPase by thapsigargin analogs induces cell death via ER Ca2+ depletion and the unfolded protein response. J. Biol. Chem. 2017, 292, 19656–19673. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Gao, J.; Fan, M.; Peng, S.; Zhang, M.; Xiang, G.; Li, X.; Guo, W.; Sun, Y.; Wu, X.; Wu, X.; et al. Small-molecule RL71-triggered excessive autophagic cell death as a potential therapeutic strategy in triple-negative breast cancer. Cell Death Dis. 2017, 8, e3049. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Zong, W.X.; Rabinowitz, J.D.; White, E. Mitochondria and Cancer. Mol. Cell 2016, 61, 667–676. [Google Scholar] [CrossRef] [Green Version]
- Curry, M.C.; Peters, A.A.; Kenny, P.A.; Roberts-Thomson, S.J.; Monteith, G.R. Mitochondrial calcium uniporter silencing potentiates caspase-independent cell death in MDA-MB-231 breast cancer cells. Biochem. Biophys. Res. Commun. 2013, 434, 695–700. [Google Scholar] [CrossRef] [Green Version]
- Tosatto, A.; Sommaggio, R.; Kummerow, C.; Bentham, R.B.; Blacker, T.S.; Berecz, T.; Duchen, M.R.; Rosato, A.; Bogeski, I.; Szabadkai, G.; et al. The mitochondrial calcium uniporter regulates breast cancer progression via HIF-1a. EMBO Mol. Med. 2016, 8, 569–585. [Google Scholar] [CrossRef]
- Tang, S.; Wang, X.; Shen, Q.; Yang, X.; Yu, C.; Cai, C.; Cai, G.; Meng, X.; Zou, F. Mitochondrial Ca2+ uniporter is critical for store-operated Ca2+ entry-dependent breast cancer cell migration. Biochem. Biophys. Res. Commun. 2015, 458, 186–193. [Google Scholar] [CrossRef]
- Brown, E.M.; MacLeod, R.J. Extracellular calcium sensing and extracellular calcium signaling. Physiol. Rev. 2001, 81, 239–297. [Google Scholar] [CrossRef]
- Kim, W.; Wysolmerski, J.J. Calcium-Sensing Receptor in Breast Physiology and Cancer. Front. Physiol. 2016, 7, 440. [Google Scholar] [CrossRef] [Green Version]
- Sanders, J.L.; Chattopadhyay, N.; Kifor, O.; Yamaguchi, T.; Butters, R.R.; Brown, E.M. Extracellular Calcium-Sensing Receptor Expression and Its Potential Role in Regulating Parathyroid Hormone-Related Peptide Secretion in Human Breast Cancer Cell Lines. Endocrinology 2000, 141, 4357–4364. [Google Scholar] [CrossRef] [PubMed]
- Liu, G.; Hu, X.; Chakrabarty, S. Calcium sensing receptor down-regulates malignant cell behavior and promotes chemosensitivity in human breast cancer cells. Cell Calcium 2009, 45, 216–225. [Google Scholar] [CrossRef] [PubMed]
- Vanhouten, J.N.; Wysolmerski, J.J. The calcium-sensing receptor in the breast. Best Pract. Res. Clin. Endocrinol. Metab. 2013, 27, 403–414. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Fuchs, A.; Lirk, P.; Stucky, C.; Abram, S.E.; Hogan, Q.H. Painful nerve injury decreases resting cytosolic calcium concentrations in sensory neurons of rats. Anesthesiology 2005, 102, 1217–1225. [Google Scholar] [CrossRef] [PubMed]
- Fuchs, A.; Rigaud, M.; Hogan, Q.H. Painful nerve injury shortens the intracellular Ca2+ signal in axotomized sensory neurons of rats. Anesthesiology 2007, 107, 106–116. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hogan, Q.H. Role of decreased sensory neuron membrane calcium currents in the genesis of neuropathic pain. Croat Med. J. 2007, 48, 9–21. [Google Scholar]
- Woolf, C.J.; Salter, M.W. Neuronal plasticity: Increasing the gain in pain. Science 2000, 288, 1765–1769. [Google Scholar] [CrossRef]
- Wu, L.J.; Zhuo, M. Targeting the NMDA receptor subunit NR2B for the treatment of neuropathic pain. Neurotherapeutics 2009, 6, 693–702. [Google Scholar] [CrossRef] [Green Version]
- Zhuo, M.; Wu, G.; Wu, L.J. Neuronal and microglial mechanisms of neuropathic pain. Mol. Brain 2011, 4, 31. [Google Scholar] [CrossRef] [Green Version]
- Gangadharan, V.; Wang, R.; Ulzhöfer, B.; Luo, C.; Bardoni, R.; Bali, K.K.; Agarwal, N.; Tegeder, I.; Hildebrandt, U.; Nagy, G.G.; et al. Peripheral calcium-permeable AMPA receptors regulate chronic inflammatory pain in mice. J. Clin. Investig. 2011, 121, 1608–1623. [Google Scholar] [CrossRef] [Green Version]
- Hartmann, B.; Ahmadi, S.; Heppenstall, P.A.; Lewin, G.R.; Schott, C.; Borchardt, T.; Seeburg, P.H.; Zeilhofer, H.U.; Sprengel, R.; Kuner, R. The AMPA receptor subunits GluR-A and GluR-B reciprocally modulate spinal synaptic plasticity and inflammatory pain. Neuron 2004, 44, 637–650. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Youn, D.H.; Royle, G.; Kolaj, M.; Vissel, B.; Randić, M. Enhanced LTP of primary afferent neurotransmission in AMPA receptor GluR2-deficient mice. Pain 2008, 136, 158–167. [Google Scholar] [CrossRef] [PubMed]
- Luo, C.; Seeburg, P.H.; Sprengel, R.; Kuner, R. Activity-dependent potentiation of calcium signals in spinal sensory networks in inflammatory pain states. Pain 2008, 140, 358–367. [Google Scholar] [CrossRef] [PubMed]
- Cruz, C.D.; Cruz, F. The ERK 1 and 2 pathway in the nervous system: From basic aspects to possible clinical applications in pain and visceral dysfunction. Curr. Neuropharmacol. 2007, 5, 244–252. [Google Scholar] [CrossRef] [Green Version]
- Kaczmarek-Hájek, K.; Lörinczi, E.; Hausmann, R.; Nicke, A. Molecular and functional properties of P2X receptors–recent progress and persisting challenges. Purinergic Signal. 2012, 8, 375–417. [Google Scholar] [CrossRef] [Green Version]
- Kim, C.; Chung, J.M.; Chung, K. Changes in the gene expression of six subtypes of P2X receptors in rat dorsal root ganglion after spinal nerve ligation. Neurosci. Lett. 2003, 337, 81–84. [Google Scholar] [CrossRef]
- Kuroda, H.; Shibukawa, Y.; Soya, M.; Masamura, A.; Kasahara, M.; Tazaki, M.; Ichinohe, T. Expression of P2X1 and P2X4 receptors in rat trigeminal ganglion neurons. Neuroreport 2012, 23, 752–756. [Google Scholar] [CrossRef]
- Fabbretti, E. ATP P2X3 receptors and neuronal sensitization. Front. Cell. Neurosci. 2013, 7, 236. [Google Scholar] [CrossRef] [Green Version]
- Jarvis, M.F. The neural-glial purinergic receptor ensemble in chronic pain states. Trends Neurosci. 2010, 33, 48–57. [Google Scholar] [CrossRef]
- D’Arco, M.; Giniatullin, R.; Simonetti, M.; Fabbro, A.; Nair, A.; Nistri, A.; Fabbretti, E. Neutralization of nerve growth factor induces plasticity of ATP-sensitive P2X3 receptors of nociceptive trigeminal ganglion neurons. J. Neurosci. 2007, 27, 8190–8201. [Google Scholar] [CrossRef]
- Giniatullin, R.; Nistri, A.; Fabbretti, E. Molecular mechanisms of sensitization of pain-transducing P2X3 receptors by the migraine mediators CGRP and NGF. Mol. Neurobiol. 2008, 37, 83–90. [Google Scholar] [CrossRef] [PubMed]
- Shrivastava, A.N.; Triller, A.; Sieghart, W.; Sarto-Jackson, I. Regulation of GABA(A) receptor dynamics by interaction with purinergic P2X(2) receptors. J. Biol. Chem. 2011, 286, 14455–14468. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sokolova, E.; Nistri, A.; Giniatullin, R. Negative cross talk between anionic GABAA and cationic P2X ionotropic receptors of rat dorsal root ganglion neurons. J. Neurosci. 2001, 21, 4958–4968. [Google Scholar] [CrossRef] [PubMed]
- Bourinet, E.; Altier, C.; Hildebrand, M.E.; Trang, T.; Salter, M.W.; Zamponi, G.W. Calcium-permeable ion channels in pain signaling. Physiol. Rev. 2014, 94, 81–140. [Google Scholar] [CrossRef]
- Cheong, E.; Shin, H.S. T-type Ca2+ channels in normal and abnormal brain functions. Physiol. Rev. 2013, 93, 961–992. [Google Scholar] [CrossRef] [Green Version]
- Todorovic, S.M.; Jevtovic-Todorovic, V. T-type voltage-gated calcium channels as targets for the development of novel pain therapies. Br. J. Pharmacol. 2011, 163, 484–495. [Google Scholar] [CrossRef] [Green Version]
- McCallum, J.B.; Kwok, W.M.; Mynlieff, M.; Bosnjak, Z.J.; Hogan, Q.H. Loss of T-type calcium current in sensory neurons of rats with neuropathic pain. Anesthesiology 2003, 98, 209–216. [Google Scholar] [CrossRef]
- Wen, X.J.; Xu, S.Y.; Chen, Z.X.; Yang, C.X.; Liang, H.; Li, H. The roles of T-type calcium channel in the development of neuropathic pain following chronic compression of rat dorsal root ganglia. Pharmacology 2010, 85, 295–300. [Google Scholar] [CrossRef]
- Dolphin, A.C. The α2β subunits of voltage-gated calcium channels. Biochim. Biophys. Acta 2013, 1828, 1541–1549. [Google Scholar] [CrossRef] [Green Version]
- Li, C.Y.; Zhang, X.L.; Matthews, E.A.; Li, K.W.; Kurwa, A.; Boroujerdi, A.; Gross, J.; Gold, M.S.; Dickenson, A.H.; Feng, G.; et al. Calcium channel alpha2delta1 subunit mediates spinal hyperexcitability in pain modulation. Pain 2006, 125, 20–34. [Google Scholar] [CrossRef] [Green Version]
- Patel, R.; Bauer, C.S.; Nieto-Rostro, M.; Margas, W.; Ferron, L.; Chaggar, K.; Crews, K.; Ramirez, J.D.; Bennett, D.L.H.; Schwartz, A.; et al. α2β-1 gene deletion affects somatosensory neuron function and delays mechanical hypersensitivity in response to peripheral nerve damage. J. Neurosci. 2013, 33, 16412–16426. [Google Scholar] [CrossRef] [PubMed]
- Boroujerdi, A.; Kim, H.K.; Lyu, Y.S.; Kim, D.S.; Figueroa, K.W.; Chung, J.M.; Luo, Z.D. Injury discharges regulate calcium channel alpha-2-delta-1 subunit upregulation in the dorsal horn that contributes to initiation of neuropathic pain. Pain 2008, 139, 358–366. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Li, C.Y.; Song, Y.H.; Higuera, E.S.; Luo, Z.D. Spinal dorsal horn calcium channel alpha2delta-1 subunit upregulation contributes to peripheral nerve injury-induced tactile allodynia. J. Neurosci. 2004, 24, 8494–8499. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Li, K.W.; Yu, Y.P.; Zhou, C.; Kim, D.S.; Lin, B.; Sharp, K.; Steward, O.; Luo, Z.D. Calcium channel α2β1 proteins mediate trigeminal neuropathic pain states associated with aberrant excitatory synaptogenesis. J. Biol. Chem. 2014, 289, 7025–7037. [Google Scholar] [CrossRef] [Green Version]
- Nieto-Rostro, M.; Ramgoolam, K.; Pratt, W.S.; Kulik, A.; Dolphin, A.C. Ablation of α2β-1 inhibits cell-surface trafficking of endogenous N-type calcium channels in the pain pathway in vivo. Proc. Natl. Acad. Sci. USA 2018, 115, E12043–E12052. [Google Scholar] [CrossRef] [Green Version]
- Davies, A.; Hendrich, J.; Van Minh, A.T.; Wratten, J.; Douglas, L.; Dolphin, A.C. Functional biology of the alpha(2)delta subunits of voltage-gated calcium channels. Trends Pharmacol. Sci. 2007, 28, 220–228. [Google Scholar] [CrossRef]
- Hendrich, J.; Van Minh, A.T.; Heblich, F.; Nieto-Rostro, M.; Watschinger, K.; Striessnig, J.; Wratten, J.; Davies, A.; Dolphin, A.C. Pharmacological disruption of calcium channel trafficking by the alpha2delta ligand gabapentin. Proc. Natl. Acad. Sci. USA 2008, 105, 3628–3633. [Google Scholar] [CrossRef] [Green Version]
- Meng, L.; Liu, B.; Ji, R.; Jiang, X.; Yan, X.; Xin, Y. Targeting the BDNF/TrkB pathway for the treatment of tumors. Oncol. Lett. 2019, 17, 2031–2039. [Google Scholar] [CrossRef] [Green Version]
- McKelvey, L.; Shorten, G.D.; O’Keeffe, G.W. Nerve growth factor-mediated regulation of pain signalling and proposed new intervention strategies in clinical pain management. J. Neurochem. 2013, 124, 276–289. [Google Scholar] [CrossRef]
- Stone, L.S.; Molliver, D.C. In search of analgesia: Emerging roles of GPCRs in pain. Mol. Interv. 2009, 9, 234–251. [Google Scholar] [CrossRef] [Green Version]
- Trang, T.; Beggs, S.; Salter, M.W. Brain-derived neurotrophic factor from microglia: A molecular substrate for neuropathic pain. Neuron Glia Biol. 2011, 7, 99–108. [Google Scholar] [CrossRef] [Green Version]
- Liu, X.J.; Salter, M.W. Glutamate receptor phosphorylation and trafficking in pain plasticity in spinal cord dorsal horn. Eur. J. Neurosci. 2010, 32, 278–289. [Google Scholar] [CrossRef] [PubMed]
- Li, N.; Lu, Z.Y.; Yu, L.H.; Burnstock, G.; Deng, X.M.; Ma, B. Inhibition of G protein-coupled P2Y2 receptor induced analgesia in a rat model of trigeminal neuropathic pain. Mol. Pain 2014, 10, 21. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Malin, S.A.; Molliver, D.C. Gi- and Gq-coupled ADP (P2Y) receptors act in opposition to modulate nociceptive signaling and inflammatory pain behavior. Mol. Pain 2010, 6, 21. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Borvendeg, S.J.; Gerevich, Z.; Gillen, C.; Illes, P. P2Y receptor-mediated inhibition of voltage-dependent Ca2+ channels in rat dorsal root ganglion neurons. Synapse 2003, 47, 159–161. [Google Scholar] [CrossRef]
- Gerevich, Z.; Müller, C.; Illes, P. Metabotropic P2Y1 receptors inhibit P2X3 receptor-channels in rat dorsal root ganglion neurons. Eur. J. Pharmacol. 2005, 521, 34–38. [Google Scholar] [CrossRef]
- Moriyama, T.; Iida, T.; Kobayashi, K.; Higashi, T.; Fukuoka, T.; Tsumura, H.; Leon, C.; Suzuki, N.; Inoue, K.; Gachet, C.; et al. Possible involvement of P2Y2 metabotropic receptors in ATP-induced transient receptor potential vanilloid receptor 1-mediated thermal hypersensitivity. J. Neurosci. 2003, 23, 6058–6062. [Google Scholar] [CrossRef] [Green Version]
- Gemes, G.; Bangaru, M.L.Y.; Wu, H.E.; Tang, Q.; Weihrauch, D.; Koopmeiners, A.S.; Cruikshank, J.M.; Kwok, W.M.; Hogan, Q.H. Store-Operated Ca2+ Entry in Sensory Neurons: Functional Role and the Effect of Painful Nerve Injury. J. Neurosci. 2011, 31, 3536–3549. [Google Scholar] [CrossRef] [Green Version]
- Gao, R.; Gao, X.; Xia, J.; Tian, Y.; Barrett, J.E.; Dai, Y.; Hu, H. Potent analgesic effects of a store-operated calcium channel inhibitor. Pain 2013, 154, 2034–2044. [Google Scholar] [CrossRef] [Green Version]
- Huang, W.; Wang, H.; Galligan, J.J.; Wang, D.H. Transient receptor potential vanilloid subtype 1 channel mediated neuropeptide secretion and depressor effects: Role of endoplasmic reticulum associated Ca2+ release receptors in rat dorsal root ganglion neurons. J. Hypertens. 2008, 26, 1966–1975. [Google Scholar] [CrossRef] [Green Version]
- Ouyang, K.; Zheng, H.; Qin, X.; Zhang, C.; Yang, D.; Wang, X.; Wu, C.; Zhou, Z.; Cheng, H. Ca2+ sparks and secretion in dorsal root ganglion neurons. Proc. Natl. Acad. Sci. USA 2005, 102, 12259–12264. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ferrari, L.F.; Bogen, O.; Levine, J.D. Role of nociceptor αCaMKII in transition from acute to chronic pain (hyperalgesic priming) in male and female rats. J. Neurosci. 2013, 33, 11002–11011. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Cheng, L.Z.; Lü, N.; Zhang, Y.Q.; Zhao, Z.Q. Ryanodine receptors contribute to the induction of nociceptive input-evoked long-term potentiation in the rat spinal cord slice. Mol. Pain 2010, 6, 1. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lü, N.; Cheng, L.Z.; Zhang, Y.Q.; Lü, B.C.; Li, Y.Q.; Zhao, Z.Q. Involvement of ryanodine receptors in tetanic sciatic stimulation-induced long-term potentiation of spinal dorsal horn and persistent pain in rats. J. Neurosci. Res. 2012, 90, 1096–1104. [Google Scholar] [CrossRef]
- Naka, A.; Gruber-Schoffnegger, D.; Sandkühler, J. Non-Hebbian plasticity at C-fiber synapses in rat spinal cord lamina I neurons. Pain 2013, 154, 1333–1342. [Google Scholar] [CrossRef] [Green Version]
- Shutov, L.P.; Kim, M.S.; Houlihan, P.R.; Medvedeva, Y.V.; Usachev, Y.M. Mitochondria and plasma membrane Ca2+-ATPase control presynaptic Ca2+ clearance in capsaicin-sensitive rat sensory neurons. J. Physiol. 2013, 591, 2443–2462. [Google Scholar] [CrossRef]
- Pottorf, W.J.; Thayer, S.A. Transient rise in intracellular calcium produces a long-lasting increase in plasma membrane calcium pump activity in rat sensory neurons. J. Neurochem. 2002, 83, 1002–1008. [Google Scholar] [CrossRef] [Green Version]
- Gemes, G.; Oyster, K.D.; Pan, B.; Wu, H.E.; Bangaru, M.L.Y.; Tang, Q.; Hogan, Q.H. Painful nerve injury increases plasma membrane Ca2+-ATPase activity in axotomized sensory neurons. Mol. Pain 2012, 8, 46. [Google Scholar] [CrossRef] [Green Version]
- Canitano, A.; Papa, M.; Boscia, F.; Castaldo, P.; Sellitti, S.; Taglialatela, M.; Annunziato, L. Brain distribution of the Na+/Ca2+ exchanger-encoding genes NCX1, NCX2, and NCX3 and their related proteins in the central nervous system. Ann. N. Y. Acad. Sci. 2002, 976, 394–404. [Google Scholar] [CrossRef]
- Persson, A.K.; Black, J.A.; Gasser, A.; Cheng, X.; Fischer, T.Z.; Waxman, S.G. Sodium-calcium exchanger and multiple sodium channel isoforms in intra-epidermal nerve terminals. Mol. Pain 2010, 6, 84. [Google Scholar] [CrossRef] [Green Version]
- Muthuraman, A.; Jaggi, A.S.; Singh, N.; Singh, D. Ameliorative effects of amiloride and pralidoxime in chronic constriction injury and vincristine induced painful neuropathy in rats. Eur. J. Pharmacol. 2008, 587, 104–111. [Google Scholar] [CrossRef]
- Ledeen, R.; Wu, G. GM1 in the nuclear envelope regulates nuclear calcium through association with a nuclear sodium-calcium exchanger. J. Neurochem. 2007, 103 (Suppl. 1), 126–134. [Google Scholar] [CrossRef] [PubMed]
- Drago, I.; Pizzo, P.; Pozzan, T. After half a century mitochondrial calcium in- and efflux machineries reveal themselves. EMBO J. 2011, 30, 4119–4125. [Google Scholar] [CrossRef] [Green Version]
- Shishkin, V.; Potapenko, E.; Kostyuk, E.; Girnyk, O.; Voitenko, N.; Kostyuk, P. Role of mitochondria in intracellular calcium signaling in primary and secondary sensory neurones of rats. Cell Calcium 2002, 32, 121–130. [Google Scholar] [CrossRef]
- Dedov, V.N.; Roufogalis, B.D. Mitochondrial calcium accumulation following activation of vanilloid (VR1) receptors by capsaicin in dorsal root ganglion neurons. Neuroscience 2000, 95, 183–188. [Google Scholar] [CrossRef]
- Kim, H.Y.; Lee, K.Y.; Lu, Y.; Wang, J.; Cui, L.; Kim, S.J.; Chung, J.M.; Chung, K. Mitochondrial Ca(2+) uptake is essential for synaptic plasticity in pain. J. Neurosci. 2011, 31, 12982–12991. [Google Scholar] [CrossRef]
- Medvedeva, Y.V.; Kim, M.S.; Usachev, Y.M. Mechanisms of prolonged presynaptic Ca2+ signaling and glutamate release induced by TRPV1 activation in rat sensory neurons. J. Neurosci. 2008, 28, 5295–5311. [Google Scholar] [CrossRef] [Green Version]
- Mach, D.B.; Rogers, S.D.; Sabino, M.C.; Luger, N.M.; Schwei, M.J.; Pomonis, J.D.; Keyser, C.P.; Clohisy, D.R.; Adams, D.J.; O’Leary, P.; et al. Origins of skeletal pain: Sensory and sympathetic innervation of the mouse femur. Neuroscience 2002, 113, 155–166. [Google Scholar] [CrossRef]
- Mantyh, P. Bone cancer pain: Causes, consequences, and therapeutic opportunities. Pain 2013, 154 (Suppl. 1), S54–S62. [Google Scholar] [CrossRef]
- Martin, C.D.; Jimenez-Andrade, J.M.; Ghilardi, J.R.; Mantyh, P.W. Organization of a unique net-like meshwork of CGRP+ sensory fibers in the mouse periosteum: Implications for the generation and maintenance of bone fracture pain. Neurosci. Lett. 2007, 427, 148–152. [Google Scholar] [CrossRef] [Green Version]
- Delmas, P.; Hao, J.; Rodat-Despoix, L. Molecular mechanisms of mechanotransduction in mammalian sensory neurons. Nat. Rev. Neurosci. 2011, 12, 139–153. [Google Scholar] [CrossRef] [PubMed]
- Yoneda, T.; Hiasa, M.; Nagata, Y.; Okui, T.; White, F.A. Acidic microenvironment and bone pain in cancer-colonized bone. Bonekey Rep. 2015, 4, 690. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Fornetti, J.; Welm, A.L.; Stewart, S.A. Understanding the Bone in Cancer Metastasis. J. Bone Min. Res. 2018, 33, 2099–2113. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Mantyh, P.W. The neurobiology of skeletal pain. Eur. J. Neurosci. 2014, 39, 508–519. [Google Scholar] [CrossRef] [Green Version]
- Mercadante, S. Malignant bone pain: Pathophysiology and treatment. Pain 1997, 69, 1–18. [Google Scholar] [CrossRef]
- Alles, S.R.A.; Smith, P.A. Etiology and Pharmacology of Neuropathic Pain. Pharmacol. Rev. 2018, 70, 315–347. [Google Scholar] [CrossRef]
- Ismy, J.; Emril, D.R.; Rizkidawati. Management of cancer pain with analgetic adjuvant and weak opioid in prostate cancer bone metastases: A case series. Ann. Med. Surg. 2020, 60, 575–578. [Google Scholar] [CrossRef]
- Lindqvist, A.; Rivero-Melian, C.; Turan, I.; Fried, K. Neuropeptide- and tyrosine hydroxylase-immunoreactive nerve fibers in painful Morton’s neuromas. Muscle Nerve 2000, 23, 1214–1218. [Google Scholar] [CrossRef]
- Jänig, W.; Baron, R. Complex regional pain syndrome: Mystery explained? Lancet Neurol. 2003, 2, 687–697. [Google Scholar] [CrossRef]
- Black, J.A.; Nikolajsen, L.; Kroner, K.; Jensen, T.S.; Waxman, S.G. Multiple sodium channel isoforms and mitogen-activated protein kinases are present in painful human neuromas. Ann. Neurol. 2008, 64, 644–653. [Google Scholar] [CrossRef]
- Ceyhan, G.O.; Bergmann, F.; Kadihasanoglu, M.; Altintas, B.; Demir, I.E.; Hinz, U.; Müller, M.W.; Giese, T.; Büchler, M.W.; Giese, N.A.; et al. Pancreatic neuropathy and neuropathic pain—A comprehensive pathomorphological study of 546 cases. Gastroenterology 2009, 136, 177–186.e1. [Google Scholar] [CrossRef] [PubMed]
- Cohen, S.P.; Chang, D.; Hsu, E.; Hottinger, D. Anti-nerve growth factor in pain management: Current evidence. J. Pain Res. 2016, 9, 373–383. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Meldolesi, J. Neurotrophin Trk Receptors: New Targets for Cancer Therapy. Rev. Physiol. Biochem. Pharmacol. 2018, 174, 67–79. [Google Scholar] [CrossRef] [PubMed]
- Vanhecke, E.; Adriaenssens, E.; Verbeke, S.; Meignan, S.; Germain, E.; Berteaux, N.; Nurcombe, V.; Le Bourhis, X.; Hondermarck, H. Brain-derived neurotrophic factor and neurotrophin-4/5 are expressed in breast cancer and can be targeted to inhibit tumor cell survival. Clin. Cancer Res. 2011, 17, 1741–1752. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Huang, Y. Expression of BDNF in dorsal root ganglion of rats with bone cancer pain and its effect on pain behavior. J. Musculoskelet. Neuronal Interact. 2018, 18, 42–46. [Google Scholar]
- Kohno, N.; Aogi, K.; Minami, H.; Nakamura, S.; Asaga, T.; Iino, Y.; Watanabe, T.; Goessl, C.; Ohashi, Y.; Takashima, S. Zoledronic acid significantly reduces skeletal complications compared with placebo in Japanese women with bone metastases from breast cancer: A randomized, placebo-controlled trial. J. Clin. Oncol. 2005, 23, 3314–3321. [Google Scholar] [CrossRef]
- Cleeland, C.S.; Body, J.J.; Stopeck, A.; von Moos, R.; Fallowfield, L.; Mathias, S.D.; Patrick, D.L.; Clemons, M.; Tonkin, K.; Masuda, N.; et al. Pain outcomes in patients with advanced breast cancer and bone metastases: Results from a randomized, double-blind study of denosumab and zoledronic acid. Cancer 2013, 119, 832–838. [Google Scholar] [CrossRef]
- Honore, P.; Luger, N.M.; Sabino, M.A.; Schwei, M.J.; Rogers, S.D.; Mach, D.B.; O’keefe, P.F.; Ramnaraine, M.L.; Clohisy, D.R.; Mantyh, P.W. Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord. Nat. Med. 2000, 6, 521–528. [Google Scholar] [CrossRef]
- Ganapathy-Kanniappan, S. Molecular intricacies of aerobic glycolysis in cancer: Current insights into the classic metabolic phenotype. Crit. Rev. Biochem. Mol. Biol. 2018, 53, 667–682. [Google Scholar] [CrossRef]
- Lozano-Ondoua, A.N.; Symons-Liguori, A.M.; Vanderah, T.W. Cancer-induced bone pain: Mechanisms and models. Neurosci. Lett. 2013, 557 Pt A, 52–59. [Google Scholar] [CrossRef] [Green Version]
- Mantyh, P.W. Cancer pain and its impact on diagnosis, survival and quality of life. Nat. Rev. Neurosci. 2006, 7, 797–809. [Google Scholar] [CrossRef]
- Parks, S.K.; Chiche, J.; Pouysségur, J. Disrupting proton dynamics and energy metabolism for cancer therapy. Nat. Rev. Cancer 2013, 13, 611–623. [Google Scholar] [CrossRef] [PubMed]
- Caterina, M.J.; Leffler, A.; Malmberg, A.B.; Martin, W.J.; Trafton, J.; Petersen-Zeitz, K.R.; Koltzenburg, M.; Basbaum, A.I.; Julius, D. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 2000, 288, 306–313. [Google Scholar] [CrossRef]
- Xu, Q.; Zhang, X.M.; Duan, K.Z.; Gu, X.Y.; Han, M.; Liu, B.L.; Zhao, Z.Q.; Zhang, Y.Q. Peripheral TGF-β1 signaling is a critical event in bone cancer-induced hyperalgesia in rodents. J. Neurosci. 2013, 33, 19099–19111. [Google Scholar] [CrossRef] [Green Version]
- Li, Y.; Cai, J.; Han, Y.; Xiao, X.; Meng, X.L.; Su, L.; Liu, F.Y.; Xing, G.G.; Wan, Y. Enhanced function of TRPV1 via up-regulation by insulin-like growth factor-1 in a rat model of bone cancer pain. Eur. J. Pain 2014, 18, 774–784. [Google Scholar] [CrossRef]
- Ghilardi, J.R.; Röhrich, H.; Lindsay, T.H.; Sevcik, M.A.; Schwei, M.J.; Kubota, K.; Halvorson, K.G.; Poblete, J.; Chaplan, S.R.; Dubin, A.E.; et al. Selective blockade of the capsaicin receptor TRPV1 attenuates bone cancer pain. J. Neurosci. 2005, 25, 3126–3131. [Google Scholar] [CrossRef]
- Peters, C.M.; Ghilardi, J.R.; Keyser, C.P.; Kubota, K.; Lindsay, T.H.; Luger, N.M.; Mach, D.B.; Schwei, M.J.; Sevcik, M.A.; Mantyh, P.W. Tumor-induced injury of primary afferent sensory nerve fibers in bone cancer pain. Exp. Neurol. 2005, 193, 85–100. [Google Scholar] [CrossRef]
- Honoré, P.; Schwei, J.; Rogers, S.D.; Salak-Johnson, J.L.; Finke, M.P.; Ramnaraine, M.L.; Clohisy, D.R.; Mantyh, P.W. Cellular and neurochemical remodeling of the spinal cord in bone cancer pain. Prog. Brain Res. 2000, 129, 389–397. [Google Scholar] [CrossRef]
- Urch, C.E.; Donovan-Rodriguez, T.; Dickenson, A.H. Alterations in dorsal horn neurones in a rat model of cancer-induced bone pain. Pain 2003, 106, 347–356. [Google Scholar] [CrossRef]
- Donovan-Rodriguez, T.; Dickenson, A.H.; Urch, C.E. Superficial dorsal horn neuronal responses and the emergence of behavioural hyperalgesia in a rat model of cancer-induced bone pain. Neurosci. Lett. 2004, 360, 29–32. [Google Scholar] [CrossRef]
- Donovan-Rodriguez, T.; Dickenson, A.H.; Urch, C.E. Gabapentin normalizes spinal neuronal responses that correlate with behavior in a rat model of cancer-induced bone pain. Anesthesiology 2005, 102, 132–140. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Bortolin, A.; Neto, E.; Lamghari, M. Calcium Signalling in Breast Cancer Associated Bone Pain. Int. J. Mol. Sci. 2022, 23, 1902. https://doi.org/10.3390/ijms23031902
Bortolin A, Neto E, Lamghari M. Calcium Signalling in Breast Cancer Associated Bone Pain. International Journal of Molecular Sciences. 2022; 23(3):1902. https://doi.org/10.3390/ijms23031902
Chicago/Turabian StyleBortolin, Andrea, Estrela Neto, and Meriem Lamghari. 2022. "Calcium Signalling in Breast Cancer Associated Bone Pain" International Journal of Molecular Sciences 23, no. 3: 1902. https://doi.org/10.3390/ijms23031902